From July 2013 to June 2014, the proton pump inhibitor Nexium was the third most-prescribed drug in the United States, according to a Medscape report.
During the data period, approximately 18.6 million Nexium prescriptions were written. Nexium came close on the heels of hypothyroidism drug levothyroxine (22.6 million prescriptions) and cholesterol-lowering drug Crestor (22.5 million prescriptions).
Nexium netted $6.3 billion in sales, tied with Humira for the second top-selling drug during the data period. Notably, hepatitis C drug Sovaldi generated $4.4 billion in sales.
More Articles on Gastroenterology:
Endoscopy device market to reach $36.9B in 2019
7 gastroenterologists making the news
Young gastroenterologists: the essential skills to thrive in healthcare today
During the data period, approximately 18.6 million Nexium prescriptions were written. Nexium came close on the heels of hypothyroidism drug levothyroxine (22.6 million prescriptions) and cholesterol-lowering drug Crestor (22.5 million prescriptions).
Nexium netted $6.3 billion in sales, tied with Humira for the second top-selling drug during the data period. Notably, hepatitis C drug Sovaldi generated $4.4 billion in sales.
More Articles on Gastroenterology:
Endoscopy device market to reach $36.9B in 2019
7 gastroenterologists making the news
Young gastroenterologists: the essential skills to thrive in healthcare today